Evolent Health, Inc. (EVH) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $2.51. It has a SharesGrow Score of 40/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of EVH = $265.10 (+10461.8% from the current price, the stock appears undervalued). Analyst consensus target is EVH = $6 (+154.2% upside).
Valuation: EVH trades at a trailing Price-to-Earnings (P/E) of -0.5 (S&P 500 average ~25).
Financials: revenue is $1.9B, +16.3%/yr average growth. Net income is $535M (loss), growing at -408.8%/yr. Net profit margin is -28.5% (negative). Gross margin is 15.1% (-8.3 pp trend).
Balance sheet: total debt is $990M against $415M equity (Debt-to-Equity (D/E) ratio 2.38, leveraged). Current ratio is 1.31 (adequate). Debt-to-assets is 52.1%. Total assets: $1.9B.
Analyst outlook: 23 / 29 analysts rate EVH as buy (79%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 48/100 (Partial), Past 0/100 (Fail), Health 17/100 (Fail), Moat 19/100 (Fail), Future 85/100 (Pass), Income 10/100 (Fail).
